Terrie Curran, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 38,200 shares at $25.03 ($956K) on 2026-08-27, disclosed to the SEC on 2026-08-28.
Open-market sale of $956k ARQT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.03 | 11,148 | $279K | 29.2% |
| 2 | $25.03 | 27,052 | $677K | 70.8% |
| Total | $25.03 avg | 38,200 | $956K | 100% |
| Filing → |
| ARQT | SELL | 2024-11-13 | $189K | — | Filing → |
| PHAT | SELL | 2024-07-17 | $793K | — | Filing → |
| PHAT | SELL | 2024-03-26 | $307K | — | Filing → |